- Home
- JAZZ vs IDCC Comparison
JAZZ vs IDCC Comparison
Compare JAZZ & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- IDCC
- Stock Information
- Founded
- JAZZ 2003
- IDCC 1972
- Country
- JAZZ Ireland
- IDCC United States
- Employees
- JAZZ N/A
- IDCC N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- IDCC Multi-Sector Companies
- Sector
- JAZZ Health Care
- IDCC Miscellaneous
- Exchange
- JAZZ Nasdaq
- IDCC Nasdaq
- Market Cap
- JAZZ 6.1B
- IDCC 5.2B
- IPO Year
- JAZZ 2007
- IDCC N/A
- Fundamental
- Price
- JAZZ $97.78
- IDCC $211.38
- Analyst Decision
- JAZZ Strong Buy
- IDCC Buy
- Analyst Count
- JAZZ 13
- IDCC 2
- Target Price
- JAZZ $181.85
- IDCC $130.00
- AVG Volume (30 Days)
- JAZZ 1.3M
- IDCC 323.8K
- Earning Date
- JAZZ 05-06-2025
- IDCC 05-01-2025
- Dividend Yield
- JAZZ N/A
- IDCC 0.90%
- EPS Growth
- JAZZ 49.21
- IDCC 84.98
- EPS
- JAZZ 7.51
- IDCC 12.66
- Revenue
- JAZZ $4,064,808,000.00
- IDCC $815,481,000.00
- Revenue This Year
- JAZZ $7.60
- IDCC N/A
- Revenue Next Year
- JAZZ $3.47
- IDCC N/A
- P/E Ratio
- JAZZ $13.00
- IDCC $16.70
- Revenue Growth
- JAZZ 5.76
- IDCC 33.52
- 52 Week Low
- JAZZ $95.49
- IDCC $105.28
- 52 Week High
- JAZZ $148.06
- IDCC $231.97
- Technical
- Relative Strength Index (RSI)
- JAZZ 33.01
- IDCC 59.97
- Support Level
- JAZZ $97.50
- IDCC $190.40
- Resistance Level
- JAZZ $120.67
- IDCC $217.44
- Average True Range (ATR)
- JAZZ 4.33
- IDCC 6.08
- MACD
- JAZZ -0.53
- IDCC 2.36
- Stochastic Oscillator
- JAZZ 1.21
- IDCC 84.34
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.